Mapping Carbon Hotspots in Pharma Supply Chains
New framework combining LCA and network analysis reveals hidden leverage points for decarbonization in complex drug supply networks
False
New framework combining LCA and network analysis reveals hidden leverage points for decarbonization in complex drug supply networks
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 5, 2026
4 min read
Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines
October 2, 2026
1 min read
Ahead of CPHI Milan’s Sustainability Summit, Silvia Forroova and Rob Williams discuss how shared standards and supplier partnerships can turn commitments into measurable progress.
October 2, 2026
5 min read
We asked the 2026 Power List how the pharmaceutical industry can prepare for geopolitical, economic, regulatory, and scientific uncertainty
September 28, 2026
2 min read
Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner
False
Affiliations:
Specialties:
Areas of Expertise: